| Members |
targetComponentId |
| Erwinia salicis |
Brenneria salicis (organism) |
| Erwinia stewartii |
Pantoea stewartii subsp stewartii |
| Erwinia uredovora |
Pantoea ananatis (organism) |
| Erythema infectiosum virus |
Primate erythroparvovirus 1 (organism) |
| erythromycin 250 mg enterogranulat i kapsel |
Product containing precisely erythromycin 250 milligram/1 each conventional release oral capsule (clinical drug) |
| Erythromycin 250mg gastro-resistant oral capsule |
Product containing precisely erythromycin 250 milligram/1 each conventional release oral capsule (clinical drug) |
| erythromycin kapsel med modificeret udløsning a 250 mg |
Product containing precisely erythromycin 250 milligram/1 each conventional release oral capsule (clinical drug) |
| Erythromycin ethylsuccinate 100 mg/2.5mL |
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 40 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Erythromycin ethylsuccinate 100mg/2.5mL oral suspension |
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 40 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| erythromycinethylsuccinat 100 mg/2,5 ml suspension |
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 40 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Erythromycin ethylsuccinate 200mg/5mL |
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 40 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Erythromycin ethylsuccinate 200mg/5mL liquid |
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 40 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Erythromycin ethylsuccinate 200mg/5mL oral suspension |
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 40 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| erythromycinethylsuccinat 200 mg/5 ml suspension |
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 40 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Erythromycin ethylsuccinate 400mg film |
Erythromycin (as erythromycin ethyl succinate) 400 mg oral tablet |
| Erythromycin ethylsuccinate 400mg/5 mL |
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 80 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Erythromycin ethylsuccinate 400mg/5mL oral suspension |
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 80 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| erythromycinethylsuccinat 400 mg/5 ml pulver |
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 80 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| erythromycinethylsuccinat 400 mg/5 ml suspension |
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 80 milligram/1 milliliter conventional release oral suspension (clinical drug) |
| Erythromycin lactobionate 1g injection (pdr for recon) |
Product containing only erythromycin in parenteral dose form (medicinal product form) |
| erythromycinlactobionat 1 g pulver til infusionsvæske, opløsning, hætteglas |
Product containing only erythromycin in parenteral dose form (medicinal product form) |
| Erythromycin lactobionate 500mg |
Product containing precisely erythromycin (as erythromycin lactobionate) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
| Erythromycin lactobionate 500mg injection (pdr for recon) |
Product containing precisely erythromycin (as erythromycin lactobionate) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
| erythromycinlactobionat 500 mg pulver til infusionsvæske, opløsning, hætteglas |
Product containing precisely erythromycin (as erythromycin lactobionate) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
| Erythromycin lactobionate 500mg/mL injection |
Product containing precisely erythromycin (as erythromycin lactobionate) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
| Escherichia coli serotype O7:H157 |
Escherichia coli serotype O157:H7 (organism) |
| eserinsulfat 1,0 % øjendråber |
Product containing precisely physostigmine sulfate 10 milligram/1 milliliter conventional release eye solution (clinical drug) |
| esmololhydrochlorid 10 mg/ml infusionsvæske, opløsning |
Product containing only esmolol in parenteral dose form (medicinal product form) |
| Esmolol hydrochloride 10mg/mL injection solution ampule |
Product containing only esmolol in parenteral dose form (medicinal product form) |
| esmololhydrochlorid 250 mg/ml koncentrat til injektionsvæske, 10 ml ampul |
Esmolol hydrochloride 250 mg/mL solution for injection |
| esmololhydrochlorid 250 mg/ml injektionsvæske, opløsning, ampul |
Esmolol hydrochloride 250 mg/mL solution for injection |
| esomeprazol 20 mg oral suspension med forsinket udløsning |
Product containing precisely esomeprazole (as esomeprazole magnesium) 20 milligram/1 sachet granules for conventional release oral suspension (clinical drug) |
| esomeprazol 40 mg oral suspension med forsinket udløsning |
Product containing precisely esomeprazole 40 milligram/1 sachet granules for conventional release oral suspension (clinical drug) |
| Esomeprazole magnesium 20mg + naproxen 375mg delayed release tablet |
Product containing precisely esomeprazole (as esomeprazole magnesium) 20 milligram and naproxen (as naproxen sodium) 375 milligram/1 each gastro-resistant oral tablet (clinical drug) |
| Esomeprazole magnesium 20mg + naproxen 500mg delayed release tablet |
Product containing precisely esomeprazole (as esomeprazole magnesium) 20 milligram and naproxen 500 milligram/1 each gastro-resistant oral tablet (clinical drug) |
| Esomeprazole magnesium 20mg gastro-resistant oral capsule |
Esomeprazole (as esomeprazole magnesium) 20 mg oral capsule |
| esomeprazolmagnesium kapsel med modificeret udløsning a 20 mg |
Esomeprazole (as esomeprazole magnesium) 20 mg oral capsule |
| Esomeprazole magnesium 40mg gastro-resistant oral capsule |
Esomeprazole (as esomeprazole magnesium) 40 mg oral capsule |
| esomeprazolmagnesium kapsel med modificeret udløsning a 40 mg |
Esomeprazole (as esomeprazole magnesium) 40 mg oral capsule |
| Esophageal motility disorder |
Diffuse spasm of esophagus |
| Esophageal varices NOS |
Esophageal varices |
| Esophagomyotomy NEC |
Oesophagomyotomy |
| Esophagospasm |
Diffuse spasm of esophagus |
| fund vedr. oesophagus udtrykt ved TNM-systemet |
American Joint Committee on Cancer allowable value |
| Essential thrombocythaemia |
Essential thrombocythemia (disorder) |
| Estimated creatine clearance |
Estimated creatinine clearance |
| Estimated creatine clearance |
Estimated creatinine clearance |
| Estimeret kreatinin-clearance |
Estimated creatinine clearance |
| Beregnet terminsdato fra sidste normale menstruation |
Estimated date of delivery from last period |
| Estimated total energy intake |
The approximate intake in one day of all energy. |
| Estimator/valuer/assessor NOS |
Estimators/valuers/assessors |
| Estimator/valuer/assessor NOS |
Estimators/valuers/assessors |
| Estradiol |
Estradiol |
| Estradiol + norethindrone acetate 0.62mg/2.7mg |
Estradiol 2.08 microgram/hour and norethisterone acetate 5.83 microgram/hour prolonged-release transdermal patch |
| estradiol 0,025 mg/dag plaster |
Estradiol 1.04 microgram/hour prolonged-release transdermal patch |
| Estradiol 0.025mg/unt |
Estradiol 1.04 microgram/hour prolonged-release transdermal patch |
| Estradiol 0.0375mg/day |
Estradiol 1.56 microgram/hour prolonged-release transdermal patch |
| estradiol 0,0375 mg/dag plaster |
Estradiol 1.56 microgram/hour prolonged-release transdermal patch |
| Estradiol 0.05 mg/day |
Product containing precisely estradiol 2.08 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
| Estradiol 0.05mg/24 hr |
Product containing precisely estradiol 2.08 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
| Estradiol 0.05mg/day |
Product containing precisely estradiol 2.08 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
| estradiol 0,05 mg/dag plaster |
Product containing precisely estradiol 2.08 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
| estradiol 0,05 mg + norethindronacetat 0,14 mg/dag depotplaster |
Estradiol 2.08 microgram/hour and norethisterone acetate 5.83 microgram/hour prolonged-release transdermal patch |
| estradiol 0,05 mg + norethindronacetat 0,25 mg/dag depotplaster |
Product containing precisely estradiol 2.08 microgram/1 hour and norethisterone acetate 10.4 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
| Estradiol 0.06mg/day transdermal patch |
Estradiol 2.5 microgram/hour prolonged-release transdermal patch |
| Estradiol 0.075mg/day |
Estradiol 3.13 microgram/hour prolonged-release transdermal patch |
| estradiol 0,075 mg/dag plaster |
Estradiol 3.13 microgram/hour prolonged-release transdermal patch |
| Estradiol 0.1mg/day |
Product containing precisely estradiol 4.167 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
| estradiol 0,1 mg/dag plaster |
Product containing precisely estradiol 4.167 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
| estradiol 14 µg/dag depotplaster |
Estradiol 583 nanogram/hour prolonged-release transdermal patch |
| estradiol 25 µg vagitorium |
Product containing precisely estradiol 25 microgram/1 each conventional release vaginal tablet (clinical drug) |
| Estradiol 3.9mg/patch |
Product containing precisely estradiol 2.08 microgram/1 hour prolonged-release transdermal patch (clinical drug) |
| Estradiol 5.75mg |
Estradiol 3.13 microgram/hour prolonged-release transdermal patch |
| Estradiol 5.85mg |
Estradiol 3.13 microgram/hour prolonged-release transdermal patch |
| allergi over for estradiolimplantat |
Allergy to estradiol (finding) |
| Ethanoic acid |
Acetic acid |
| ethanol i blodprøve over den tilladte grænse for at føre et køretøj |
High ethanol level in blood |
| Ethanolamine agent |
Product containing ethanolamine (medicinal product) |
| ethanolaminoleat 5 % injektionsvæske, opløsning, ampul |
Product containing only ethanolamine in parenteral dose form (medicinal product form) |
| ethanolaminprodukt |
Product containing ethanolamine (medicinal product) |
| Ether hydrolase |
Ether hydrolase |
| bivirkning af anæstetisk ether |
Adverse reaction to inhaled anesthetic with ether structure |
| allergi over for anæstetisk ether |
Allergy to substance with ether structure |
| ethynylestradiol 0,02 mg + norelgestromin 0,15 mg pr. dag depotplaster |
Ethinylestradiol 1.46 microgram/hour and norelgestromin 6.25 microgram/hour prolonged-release transdermal patch |
| Røntgenundersøgelse af sinus ethmoidales |
Plain X-ray of ethmoid sinus |
| Ethmoid sinuses X-ray |
Plain X-ray of ethmoid sinus |
| Ethnic form of nose - finding |
Finding of appearance of nose |
| Ethnic group not given - patient refused |
Refusal by patient to provide information about ethnic group |
| etnisk gruppe ikke angivet - afslået af patienten |
Refusal by patient to provide information about ethnic group |
| Ethnic group not given - patient refused |
Refusal by patient to provide information about ethnic group |
| ethylenoxidspecifikt ekstrakt |
Product containing ethylene oxide (medicinal product) |
| Ethynodiol diacetate [progestogen oral contraceptive] |
Product containing etynodiol (medicinal product) |
| allergi over for ethynodioldiacetat |
Allergy to progestational hormone |
| Ethynodiol diacetate preparation |
Product containing etynodiol (medicinal product) |
| Etidocaine hydrochloride 1% injection |
Product containing precisely etidocaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| etidocainhydrochlorid 1 % injektionsvæske, opløsning, ampul |
Product containing precisely etidocaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Etidocaine hydrochloride+epinephrine 1%/1:200000 injection |
Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and etidocaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Etidocaine hydrochloride+epinephrine 1.5%/1:200000 injection |
Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and etidocaine hydrochloride 15 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| etidocainhydrochlorid + adrenalin 1,5 %/1:200.000 injektionsvæske, opløsning, hætteglas a 20 ml |
Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and etidocaine hydrochloride 15 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| etidocainhydrochlorid + adrenalin 1,5 %/1:200.000 injektionsvæske, opløsning, hætteglas a 2 ml |
Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and etidocaine hydrochloride 15 milligram/1 milliliter conventional release solution for injection (clinical drug) |
| Etidronate |
Product containing etidronic acid (medicinal product) |
FHIR